Shigehiro Yi

608 total citations
21 papers, 484 citations indexed

About

Shigehiro Yi is a scholar working on Molecular Biology, Genetics and Cell Biology. According to data from OpenAlex, Shigehiro Yi has authored 21 papers receiving a total of 484 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 7 papers in Genetics and 7 papers in Cell Biology. Recurrent topics in Shigehiro Yi's work include Amyloidosis: Diagnosis, Treatment, Outcomes (19 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers) and Trace Elements in Health (6 papers). Shigehiro Yi is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (19 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers) and Trace Elements in Health (6 papers). Shigehiro Yi collaborates with scholars based in Japan. Shigehiro Yi's co-authors include Shukuro Araki, Shuichiro Maeda, Yoshihiro Kimura, Kiyoshi Takahashi, Kazunori Shimada, T. Murakami, Kiyoshi Takahashi, Shoji Wakasugi, Kazuhiko Yamamura and Fumio Tashiro and has published in prestigious journals such as Annals of Neurology, Biochemical and Biophysical Research Communications and Human Pathology.

In The Last Decade

Shigehiro Yi

21 papers receiving 473 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shigehiro Yi Japan 13 367 171 146 60 56 21 484
B O Olofsson Sweden 12 416 1.1× 98 0.6× 51 0.3× 24 0.4× 54 1.0× 18 485
Yoshitaka Tashiro Japan 13 260 0.7× 154 0.9× 99 0.7× 10 0.2× 17 0.3× 20 505
Ichiro Nozaki Japan 13 350 1.0× 88 0.5× 33 0.2× 45 0.8× 20 0.4× 33 510
J Frøkjaer-Jensen Denmark 9 224 0.6× 153 0.9× 119 0.8× 7 0.1× 30 0.5× 12 509
Flavia Paula Brazil 14 460 1.3× 126 0.7× 135 0.9× 22 0.4× 32 0.6× 51 685
G. Ruzza Italy 9 178 0.5× 45 0.3× 85 0.6× 9 0.1× 39 0.7× 18 430
Sari Kiuru Finland 14 466 1.3× 241 1.4× 139 1.0× 39 0.7× 15 0.3× 18 642
Maike F. Dohrn Germany 13 218 0.6× 97 0.6× 72 0.5× 7 0.1× 29 0.5× 45 446
Serafí Cambray Spain 12 314 0.9× 38 0.2× 31 0.2× 17 0.3× 18 0.3× 24 560
Kensuke Takatsuki Japan 13 210 0.6× 76 0.4× 22 0.2× 22 0.4× 38 0.7× 32 506

Countries citing papers authored by Shigehiro Yi

Since Specialization
Citations

This map shows the geographic impact of Shigehiro Yi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shigehiro Yi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shigehiro Yi more than expected).

Fields of papers citing papers by Shigehiro Yi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shigehiro Yi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shigehiro Yi. The network helps show where Shigehiro Yi may publish in the future.

Co-authorship network of co-authors of Shigehiro Yi

This figure shows the co-authorship network connecting the top 25 collaborators of Shigehiro Yi. A scholar is included among the top collaborators of Shigehiro Yi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shigehiro Yi. Shigehiro Yi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Araki, Shukuro & Shigehiro Yi. (2000). Pathology of familial amyloidotic polyneuropathy with TTR Met 30 in Kumamoto, Japan. Neuropathology. 20(s1). 47–51. 14 indexed citations
2.
Takaoka, Yutaka, Fumi Tashiro, Shigehiro Yi, et al.. (1997). Comparison of amyloid deposition in two lines of transgenic mouse that model familial amyloidotic polyneuropathy, type I. Transgenic Research. 6(4). 261–269. 20 indexed citations
3.
Araki, Shukuro, et al.. (1996). Epidemiological study of familial amyloidotic polyneuropathy (FAP) in Kumamoto focus, Japan. Neuromuscular Disorders. 6. S39–S39. 4 indexed citations
4.
Nagata, Yasushi, Fumi Tashiro, Shigehiro Yi, et al.. (1995). A 6-kb Upstream Region of the Human Transthyretin Gene Can Direct Developmental, Tissue-Specific, and Quantitatively Normal Expression in Transgenic Mouse1. The Journal of Biochemistry. 117(1). 169–175. 30 indexed citations
5.
Yi, Shigehiro, et al.. (1995). Transgenic mouse model of familial amyloidotic polyneuropathy type I: its production, biological features, and usefulness.. PubMed. 45(2). 173–5. 1 indexed citations
6.
Araki, Shukuro, et al.. (1994). Systemic amyloidosis in transgenic mice carrying the human mutant transthyretin (Met 30) gene. Molecular Neurobiology. 8(1). 15–23. 22 indexed citations
7.
Yamamura, Ken‐Ichi, Fumi Tashiro, Shigehiro Yi, et al.. (1993). Transgenic mouse model for human genetic diseases. Molecular Reproduction and Development. 36(2). 248–250. 1 indexed citations
8.
Ando, Yukio, et al.. (1993). Secondary Hypoplastic Anemia in Patients with Familial Amyloidotic Polyneuropathy. Acta Haematologica. 90(3). 130–135. 12 indexed citations
9.
Murakami, T., Shigehiro Yi, Kenji Yamamoto, Shoichi Maruyama, & Shukuro Araki. (1992). Familial amyloidotic polyneuropathy: Report of patients heterozygous for the transthyretin Gly42 gene. Annals of Neurology. 31(3). 340–342. 10 indexed citations
10.
Murakami, T., et al.. (1992). A novel transthyretin mutation associated with familial amyloidotic polyneuropathy. Biochemical and Biophysical Research Communications. 182(2). 520–526. 36 indexed citations
11.
Takahashi, Kiyoshi, Shigehiro Yi, Yoshihiro Kimura, & Shukuro Araki. (1991). Familial amyloidotic polyneuropathy type 1 in Kumamoto, Japan: A clinicopathologic, histochemical, immunohistochemical, and ultrastructural study. Human Pathology. 22(6). 519–527. 89 indexed citations
12.
Ando, Yukio, Shigehiro Yi, Toshiyuki Nakagawa, et al.. (1991). Disturbed metabolism of glucose and related hormones in familial amyloidotic polyneuropathy: Hypersensitivities of the autonomic nervous system and therapeutic prevention. Journal of the Autonomic Nervous System. 35(1). 63–70. 26 indexed citations
13.
Tashiro, Fumio, Shigehiro Yi, Shoji Wakasugi, et al.. (1991). Role of Serum Amyloid P Component for Systemic Amyloidosis in Transgenic Mice Carrying Human Mutant Transthyretin Gene. Gerontology. 37(1). 56–62. 13 indexed citations
14.
Kakigi, Ryusuke, Hiroshi Shibasaki, Kaoru Tanaka, et al.. (1991). CO2 laser‐induced pain‐related somatosensory evoked potentials in peripheral neuropathies: Correlation between electrophysiological and histopathological findings. Muscle & Nerve. 14(5). 441–450. 91 indexed citations
15.
Yi, Shigehiro, Akihisa Takahashi, Munekazu Naito, et al.. (1991). Systemic amyloidosis in transgenic mice carrying the human mutant transthyretin (Met30) gene. Pathologic similarity to human familial amyloidotic polyneuropathy, type I.. PubMed. 138(2). 403–12. 55 indexed citations
16.
Yi, Shigehiro, et al.. (1988). Complicating systemic amyloidosis in dystrophic epidermolysis bullosa, recessive type. Pathology. 20(2). 184–187. 10 indexed citations
17.
Wakasugi, Shoji, Takeaki Inomoto, Shigehiro Yi, et al.. (1988). A Potential Animal Model for Familial Amyloidotic Polyneuropathy Through Introduction of Human Mutant Transthyretin Gene Into Mice. 393–398. 3 indexed citations
19.
Tanase, Sumio, Yoshimasa Morino, Shigehiro Yi, et al.. (1988). Evaluation of Serum Variant Prealbumin Levels, and its Behavior after Plasma Exchange for Familial Amyloidotic Polyneuropathy (Type 1). 839–844. 3 indexed citations
20.
Wakasugi, Shoji, Takeaki Inomoto, Shigehiro Yi, et al.. (1987). A transgenic mouse model of familial amyloidotic polyneuropathy.. Proceedings of the Japan Academy Series B. 63(9). 344–347. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026